(148 days)
No
The 510(k) summary describes a mechanical knee replacement system and its components. There is no mention of AI or ML technology in the intended use, device description, or performance studies.
Yes
The device is a total knee replacement system designed to alleviate severe pain and disability in the knee joint resulting from various conditions like arthritis, avascular necrosis, or joint configuration loss. This directly addresses health issues and aims to restore normal function, fitting the definition of a therapeutic device.
No
This device is a knee replacement system, which functions as a prosthetic to restore joint function, rather than to diagnose a condition.
No
The device description clearly states it is a set of tibial inserts and other physical components for knee replacement surgery, which are hardware, not software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical implant for replacing the articular surface of the knee joint. This is a therapeutic device, not a diagnostic one.
- Device Description: The description details the physical components of a knee replacement system (liners, baseplates, stems, etc.) and how they function mechanically within the body. This is consistent with a surgical implant.
- Lack of Diagnostic Elements: There is no mention of analyzing samples from the human body (blood, tissue, etc.) or providing information for diagnosis. The device's function is purely mechanical and structural.
- Anatomical Site: The device is used directly within the knee joint, which is a therapeutic application, not an in vitro diagnostic one.
In summary, the device is a surgical implant used for treating knee conditions, not for diagnosing them.
N/A
Intended Use / Indications for Use
The GMK® Total Knee System is designed for cemented use in total knee arthroplasty, if there is evidence of sufficient sound bone to seat and support the components.
This knee replacement system is indicated in the following cases:
- · Severely painful and/or disabled joint as a result of arthritis, traumatic arthritis, rheumatoid arthritis or polyarthritis.
- · Avascular necrosis of femoral condyle.
- · Post traumatic loss of joint configuration.
- · Primary implantation failure.
The tibial augments are to be attached to the tibial baseplate with both the fixing cylinders and bone cement.
In case a semi-constrined liner is used, an extension stem must be implanted both on the tibial and on the femoral components.
Product codes
JWH
Device Description
This modification to the original Medacta GMK® (Global Medacta Knee) Total Knee System is a line extension to include the GMK® Revision SC (Semiconstrained) liners. The GMK® Revision SC liners work with components from the GMK® Total Knee System and from the GMK® Revision, a previously cleared Special 510(k) to the GMK® Total Knee System.
The GMK® Revision SC Liners, the subject of this 510(k), are a set of tibial inserts which work with the GMK® Revision femoral PS components and the GMK® tibial baseplates. These liners provide the surgeon with an additional option. The GMK® Revision SC Liners are offered in six sizes with seven thicknesses from 10 mm to 26 mm. The GMK® Revision SC Liners are attached to the GMK® tibial baseplates of the same size from the GMK® Total Knee System using a support peg made of CoCrMo. The device is used to replace the articular surface of the tibial plateau in the knee joint by limiting the movement of the prosthetic femoral component in translation and rotation. The GMK® Revision SC Liners attached to the GMK® tibial baseplates can also be combined with an extension stem, an offset connector and tibial wedges.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
knee joint
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The modification to the GMK® Total Knee system to include the addition of the GMK® Revision SC liners was evaluated by risk analysis to identify any new risks associated with the change. Based on the risk analysis, design verification was conducted to written protocols with pre-defined acceptance criteria. The protocols and pre-defined acceptance criteria were based on the standards. FDA quidance, and comparison to the predicate device system. The testing was conducted on the worst case component size and option/design based on engineering analysis. The performance testing conducted on the GMK® Revision SC Liners was very similar to the protocols conducted for the predicate device, the GMK® Total Knee System. The testing included static and dynamic testing in the A/P direction, static testing in the M/L direction, and pullout testing of the SC liner to the tibial baseplate. Rotary/laxity and varus/valgus testing was also conducted. Range of motion and contact area were both evaluated in comparison to the predicate device. The testing met all acceptance criteria and verifies that performance of the GMK® Revision SC Liners are substantially equivalent to the predicate device system, GMK® Total Knee System.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K090988 GMK® Total Knee System (Medacta International)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3560 Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
K103170113
MAR 2 4 2011
Image /page/0/Picture/2 description: The image shows the logo for Medacta International. The logo consists of a stylized graphic element resembling two triangles, followed by the word "Medacta" in a sans-serif font. Below this, the word "International" is written in a smaller font, accompanied by a symbol resembling a plus sign.
510(k) Summary
Manufacturer:
Medacta International SA Strada Regina 6874 Castel San Pietro (CH) Switzerland Phone (+41) 91 696 60 60 FAX (+41) 91 696 60 66
Ms. Natalie J. Kennel
Contact Person:
Consultant NJK & Associates, Inc. 13721 Via Tres Vista San Diego, CA 92129 USA Phone: (858) 705-0350 Fax: (858) 764-9739 email: NKennel@njkconsulting.com
Date Prepared: March 4, 2011
DEVICE INFORMATION
| Trade/Proprietary Name: | GMK® Total Knee System- Revision
Semi-Constrained Liners |
|-------------------------|--------------------------------------------------------------------------------------------|
| Common Name | Total Knee Prosthesis – Tibial Inserts |
| Classification Name: | Knee joint patellofemorotibial metal/polymer/metal
semiconstrained cemented prosthesis, |
| Classification: | Class II, 21 CFR 888.3560 |
| Product Code: | JWH |
| Predicate Devices: | K090988 GMK® Total Knee System (Medacta
International), cleared July 10, 2009 |
Product Description:
This modification to the original Medacta GMK® (Global Medacta Knee) Total Knee System is a line extension to include the GMK® Revision SC (Semiconstrained) liners. The GMK® Revision SC liners work with components
GMK® Revision SC Liners Special 510(k)
1
from the GMK® Total Knee System and from the GMK® Revision, a previously cleared Special 510(k) to the GMK® Total Knee System.
The GMK® Revision SC Liners, the subject of this 510(k), are a set of tibial inserts which work with the GMK® Revision femoral PS components and the GMK® tibial baseplates. These liners provide the surgeon with an additional option. The GMK® Revision SC Liners are offered in six sizes with seven thicknesses from 10 mm to 26 mm. The GMK® Revision SC Liners are attached to the GMK® tibial baseplates of the same size from the GMK® Total Knee System using a support peg made of CoCrMo. The device is used to replace the articular surface of the tibial plateau in the knee joint by limiting the movement of the prosthetic femoral component in translation and rotation. The GMK® Revision SC Liners attached to the GMK® tibial baseplates can also be combined with an extension stem, an offset connector and tibial wedges.
Indications for Use:
The GMK® Total Knee System is designed for cemented use in total knee arthroplasty, if there is evidence of sufficient sound bone to seat and support the components.
This knee replacement system is indicated in the following cases:
- · Severely painful and/or disabled joint as a result of arthritis, traumatic arthritis, rheumatoid arthritis or polyarthritis.
- · Avascular necrosis of femoral condyle.
- · Post traumatic loss of joint configuration.
- · Primary implantation failure.
The tibial augments are to be attached to the tibial baseplate with both the fixing cylinders and bone cement.
In case a semi-constrined liner is used, an extension stem must be implanted both on the tibial and on the femoral components.
Comparison to Predicate Devices
The GMK® Total Knee System was cleared under K090988. GMK® Revision components, as a line extension, was cleared under a Special 510(k), K102437. The subject of this submission is the GMK® Revision SC liners, an additional line extension of this system.
The indications for use for the modified system remain the same as the original 510(k), K090988.
The GMK® Revision SC Liners are made of Ultra High Molecular Weight Polvethylene (UHMWPE), the same material and processing, as is used in the GMK® Total Knee System's standard, ultracongruent, and posteriorstabilized (PS) tibial inserts and patellas. Like the GMK® Total Knee System's PS tibial inserts, the GMK® Revision SC liners are attached to the GMK® fixed bearing tibial baseplates, cleared in the original GMK® Total
GMK® Revision SC Liners Special 510(k)
K103170(2/3)
2
Knee System. They are attached with a support peg, similar to the fixing screw used with the GMK® PS tibial inserts.
The GMK® Revision SC liners are offered in sizes 1 – 6, the same as all of the GMK® Total Knee System components. The GMK® Revision SC liners only work with the same size GMK® Tibial baseplate, similar to how the previously cleared tibial inserts work. The same tibial insert may be used with either a left or right hand GMK® Tibial baseplate in the same manner as the previously cleared tibial inserts. The GMK® Revision SC liners when attached to the GMK® Tibial baseplates allow the use of extension stems, offset connectors, and tibial wedges, identical to the other previously cleared tibial inserts.
The GMK® Revision SC liners differ from the tibial inserts in the GMK® Total Knee System in that they are offered in thicknesses from 10 mm to 26 mm instead of 10 mm to 20 mm. These additional thicknesses are provided as additional options to support the situations that the surgeon may encounter.
Performance Testing
No performance standards applicable to this device have been adopted under Section 514 of the Food, Drug and Cosmetic Act.
The modification to the GMK® Total Knee system to include the addition of the GMK® Revision SC liners was evaluated by risk analysis to identify any new risks associated with the change. Based on the risk analysis, design verification was conducted to written protocols with pre-defined acceptance criteria. The protocols and pre-defined acceptance criteria were based on the standards. FDA quidance, and comparison to the predicate device system. The testing was conducted on the worst case component size and option/design based on engineering analysis. The performance testing conducted on the GMK® Revision SC Liners was very similar to the protocols conducted for the predicate device, the GMK® Total Knee System. The testing included static and dynamic testing in the A/P direction, static testing in the M/L direction, and pullout testing of the SC liner to the tibial baseplate. Rotary/laxity and varus/valgus testing was also conducted. Range of motion and contact area were both evaluated in comparison to the predicate device. The testing met all acceptance criteria and verifies that performance of the GMK® Revision SC Liners are substantially equivalent to the predicate device system, GMK® Total Knee System.
Conclusion:
The results from design controls and the information provided in this submission support the conclusion that the GMK® Total Knee System-Revision SC Liners is substantially equivalent to its predicate device with respect to indications for use and technological characteristics.
K103170 (3/3
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an emblem featuring a stylized depiction of an eagle or bird with outstretched wings.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002
Medacta International % NJK & Associates, Inc. Ms. Natalie J. Kennel 13721 Via Tres Vista San Diego, California 92129
MAH 2 4 2011
Re: K103170
Trade/Device Name: GMK® Total Knee System - Revision SC Liners Regulation Number: 21 CFR 888.3560 Regulation Name: Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis Regulatory Class: II Product Code: JWH Dated: March 4, 2011 Received: March 7, 2011
Dear Ms. Kennel:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
4
Page 2 - Ms. Natalie J. Kennel
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 100-100.
lf you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutiFDA/CentersOffices/CDRH/CDRHOffices/ucm1 1 5809.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its tolli inc
(800) 638 204) - (2012 504) 734 700 100 Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Aiz B. R. for
Mark N. Melkerson Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use Statement
510(k) Number (if known): K103170
Device Name: GMK® Total Knee System - Revision SC Liners
Indications for Use:
The GMK® Total Knee System is designed for cemented use in total knee arthroplasty, if there is evidence of sufficient sound bone to seat and support the components.
This knee replacement system is indicated in the following cases:
- · Severely painful and/or disabled joint as a result of arthritis, traumatic arthritis, rheumatoid arthritis or polyarthritis.
- · Avascular necrosis of femoral condyle.
- · Post traumatic loss of joint configuration.
- · Primary implantation failure.
The tibial augments are to be attached to the tibial baseplate with both the fixing cylinders and bone cement.
In case a semi-constrained liner is used, an extension stem must be implanted both on the tibial and on the femoral components.
× Prescription Use Prescription Use _____________________________________________________________________________________________________________________________________________________________
Over-The-Counter Use
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
for M. Melleckson
(Division Sign-Oft) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K103170
Page __ of __